CS logo
small CS logo
Institutul de pneumoftiziologie Marius Nasta

Bucuresti, Romania
Hospital in Bucharest
Șoseaua Viilor nr. 90, București 050159

About Institutul de pneumoftiziologie Marius Nasta


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Institutul de pneumoftiziologie Marius Nasta


During the past decade, Institutul de pneumoftiziologie Marius Nasta conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
2008-05-01
2012-04-01
Completed
742
Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension
2008-10-17
2020-12-07
Completed
550
Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)
2010-02-01
2011-09-13
Completed
36
Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients
2009-11-30
2013-11-30
Completed
31
Selexipag (ACT-293987) in Pulmonary Arterial Hypertension
2009-12-01
2014-10-01
Completed
1,156
A Clinical Study to Test How Effective and Safe GLPG1205 is for Participants With Idiopathic Pulmonary Fibrosis (IPF)
2018-09-27
2020-08-14
Completed
68
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
2020-09-29
2022-12-02
Completed
763
Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
2021-05-10
2025-06-01
Recruiting
160

Rows per page:

1–9 of 9

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Institutul de pneumoftiziologie Marius Nasta" #1 sponsor was "Actelion" with 4 trials, followed by "Lung Biotechnology PBC" with 2 trials sponsored, "Galapagos NV" with 1 trials sponsored, "Savara Inc." with 1 trials sponsored and "Verona Pharma plc" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Institutul de pneumoftiziologie Marius Nasta" #1 collaborator was "Iqvia Pty Ltd" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsActelion: 4Actelion: 4Lung Biotechnology PBC: 2Lung Biotechnology PBC: 2Galapagos NV: 1Galapagos NV: 1Savara Inc.: 1Savara Inc.: 1Verona Pharma plc: 1Verona Pharma plc: 1

Created with Highcharts 11.1.0Top CollaboratorsIqvia Pty Ltd: 1Iqvia Pty Ltd: 1

Clinical Trials Conditions at Institutul de pneumoftiziologie Marius Nasta


According to Clinical.Site data, the most researched conditions in "Institutul de pneumoftiziologie Marius Nasta" are "Pulmonary Arterial Hypertension" (5 trials), "Autoimmune Pulmonary Alveolar Proteinosis" (1 trials), "Chronic Obstructive Pulmonary Disease" (1 trials), "Hypertension, Pulmonary" (1 trials) and "Idiopathic Pulmonary Fibrosis" (1 trials). Many other conditions were trialed in "Institutul de pneumoftiziologie Marius Nasta" in a lesser frequency.

Clinical Trials Intervention Types at Institutul de pneumoftiziologie Marius Nasta


Most popular intervention types in "Institutul de pneumoftiziologie Marius Nasta" are "Drug" (9 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Beraprost Sodium Modified Release" (2 trials), "Selexipag" (2 trials), "Ensifentrine" (1 trials) and "GLPG1205" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Institutul de pneumoftiziologie Marius Nasta


The vast majority of trials in "Institutul de pneumoftiziologie Marius Nasta" are 9 trials for "All" genders.

Clinical Trials Status at Institutul de pneumoftiziologie Marius Nasta


Currently, there are NaN active trials in "Institutul de pneumoftiziologie Marius Nasta". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Institutul de pneumoftiziologie Marius Nasta, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Institutul de pneumoftiziologie Marius Nasta, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 6Phase 3: 6Phase 2: 3Phase 2: 3

Created with Highcharts 11.1.0Trials StatusCompleted: 7Completed: 7Active, not recruiting: 1Active, not recruiting: 1Recruiting: 1Recruiting: 1